These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17354283)

  • 1. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of microbiology in drug monitoring.
    Kirshbaum A
    Bull Parenter Drug Assoc; 1971; 25(5):226-32. PubMed ID: 5109889
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approvals. New drugs, new uses.
    Rodman MJ
    RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204
    [No Abstract]   [Full Text] [Related]  

  • 8. New drugs.
    Hussar DA
    Nursing; 1992 May; 22(5):55-61. PubMed ID: 1584496
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of new drugs.
    Holsten DW; Weilerstein R
    Hospitals; 1972 Mar; 46(6):97-104. PubMed ID: 5009178
    [No Abstract]   [Full Text] [Related]  

  • 10. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 11. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatric drugs and trends; new regulations on vitamins and minerals.
    Dembicki EL
    J Psychiatr Nurs Ment Health Serv; 1974; 12(2):43-5. PubMed ID: 4362712
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 15. Manufacturing of drugs: interpretation of federal regulations lies in eye of beholder.
    Raef TA
    J Am Vet Med Assoc; 1990 May; 196(9):1360-1. PubMed ID: 2341312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thoughts on the improvement of the quality of the drugs prepared in the pharmacy].
    Hädicke M
    Pharm Prax; 1966 Apr; 4():103-4. PubMed ID: 6001079
    [No Abstract]   [Full Text] [Related]  

  • 17. Bulk drugs and chemical substances.
    Gushee J
    J Am Vet Med Assoc; 1986 Oct; 189(8):878-9. PubMed ID: 3771357
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic drugs and therapeutic equivalence.
    Friend DG
    JAMA; 1968 Nov; 206(8):1785. PubMed ID: 5754832
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.